Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q5OC
|
|||
| Former ID |
DNCL002623
|
|||
| Drug Name |
AGS-003
|
|||
| Indication | Migraine [ICD-11: 8A80; ICD-10: G43, G43.9] | Phase 2 | [1] | |
| Renal cell carcinoma [ICD-11: 2C90; ICD-10: C64] | Phase 2 | [1] | ||
| Company |
Argos Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01482949) A Rollover Protocol for Subjects Previously Treated With AGS-003. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.